ACCORDENGAGE
Live / Applied — Third extension granted (statement of use) (as of 28 Jan 2026)
What this means for you
Not registered yet, but its 13 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97887297
- Mark type
- Stylized text
- Filed
- 13 Apr 2023
- Published for opposition
- 12 Mar 2024
- Attorney of record
- Michele K. Robichaux
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the nature of clinical and drug information to medical professionals for use in medical education in the field of oncology, immunology, and critical care; providing medical and scientific research information to medical professionals in the field of oncology, immunology, and critical care pharmaceuticals and clinical trials
Owner
- Accord BioPharma, Inc., Raleigh, NC, US
- Accord BioPharma, Inc., Durham, NC, US
Prosecution history
- 28 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2026 — SOU EXTENSION 3 GRANTED
- 06 Nov 2025 — SOU EXTENSION 3 FILED
- 26 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Dec 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 08 Dec 2025 — NOTICE OF REVIVAL - E-MAILED
- 08 Dec 2025 — PETITION TO REVIVE-GRANTED
- 08 Dec 2025 — TEAS PETITION TO REVIVE RECEIVED
- 08 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 2 GRANTED
- 25 Apr 2025 — SOU EXTENSION 2 FILED
- 25 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED